The role of Th1/Th2 cell chemokine expression in hypertrophic scar

被引:9
|
作者
Chen, Baoguo [1 ]
Li, Huichao [1 ]
Xia, Wei [2 ]
机构
[1] Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Burs & Plast Surg, Beijing, Peoples R China
[2] Forth Mil Med Hosp, Dept Plast & Reconstruct Surg, Xian, Shaanxi, Peoples R China
关键词
chemokines; hypertrophic scar; imbalance; Th1; Th2; cell; CYTOKINE PRODUCTION; INTERFERON-ALPHA-2B;
D O I
10.1111/iwj.13257
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The aim of this study was to study the role of Th1/Th2 cell-associated chemokines in the formation of hypertrophic scars in rabbit ears. Twenty-six New Zealand white rabbits were used to establish the hypertrophic scar model of rabbit ear and the normal scar model of rabbit's back. Two rabbits were sacrificed on days 0 and 21, 28, 35, 42, 49, 56, and 63 after operation. The specimens were stained with haematoxylin-eosin (HE). Scar elevation index (SEI) was used to detect the expression of 10 chemokines related to Th1/Th2 cells in both scar formation expressions. Real-time polymerase chain reaction (PCR) results showed that two chemokines (CXCL10, CXCL12) were highly expressed during the formation of normal scar, and there was almost no expression during the formation of hypertrophic scar (*P < 0.05). The chemokines (CCL2, CCL3, CCL4, CCL5, CCL7, CCL13, CX3CL1) were almost non-expressed in the formation of normal scars but were expressed for a long time in the formation of hypertrophic scars. The four chemokines, CCL2, CCL4, CCL5, and CX3CL1, maintained a long-term high expression level during the formation of hypertrophic scars (P < 0.01). There were also three chemokines (CCL14, CCL19, CCL21) that were almost undetectable in normal scarring, but there was transiently low-level expression (P < 0.05) only during the peak proliferative phase in proliferative scarring. Th1/Th2 cell-associated chemokines are different in the type, quantity and expression, and maintenance time of rabbit ear hypertrophic scars.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [1] Differential TH1/TH2 Chemokine Expression in Interstitial Pneumonia
    Honda, Toyohiro
    Imaizumi, Kazuyoshi
    Yokoi, Toyoharu
    Hashimoto, Naozumi
    Hashimoto, Izumi
    Kawabe, Tsutomu
    Matsuo, Masaki
    Iwano, Shingo
    Shimokata, Kaoru
    Hasegawa, Yoshinori
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (01): : 41 - 48
  • [2] The chemokine receptor expression of TH1 and TH2 human bronchoalveolar cells
    Morgan, AJ
    Berry, MA
    Symon, FA
    Wardlaw, AJ
    THORAX, 2003, 58 : 16 - 16
  • [3] Th1/Th2 subsets: Distinct differences in homing and chemokine receptor expression?
    Syrbe U.
    Siveke J.
    Hamann A.
    Springer Seminars in Immunopathology, 1999, 21 (3): : 263 - 285
  • [4] Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?
    Syrbe, U
    Siveke, J
    Hamann, A
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1999, 21 (03): : 263 - 285
  • [5] Th1/Th2 cell primer
    Sanders, VM
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 16 - 16
  • [6] Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
    Annunziato, F
    Cosmi, L
    Galli, G
    Beltrame, C
    Romagnani, P
    Manetti, R
    Romagnani, S
    Maggi, E
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (05) : 691 - 699
  • [7] Differential expression of TH1/TH2 lymphocytes:: Role in postpartum immunosuppression
    Shafer-Weaver, KA
    Corl, CM
    Sodillo, LM
    FASEB JOURNAL, 1999, 13 (05): : A942 - A942
  • [8] Th1 and Th2 cell population in chronic ethmoidal rhinosinusitis: A chemokine receptor assay
    Elhini, A
    Abdelwahab, S
    Ikeda, K
    LARYNGOSCOPE, 2005, 115 (07): : 1272 - 1277
  • [9] Pathophysiological role of Th1 and Th2 cells
    Parronchi, P
    Maggi, E
    Romagnani, S
    BILE ACIDS AND IMMUNOLOGY, 1996, 86 : 11 - 22
  • [10] Roxithromycin suppression of keratinocyte Th2 chemokine production and Th2 cell chemokine receptor expression
    Kobayashi, M
    Shimauchi, T
    Hino, R
    Tokura, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A119 - A119